An over-the-counter medication for relieving gas and bloating has been recalled due to potential chemical contamination.
According to a Thursday notice from the U.S. Food and Drug Administration, manufacturing company Haleon has voluntarily recalled four lots of Gas-X Extra Strength Softgels, which were distributed to different retailers nationwide.
“The lots are being recalled due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process,” the company said in an announcement shared by the FDA.
“There is a potential that ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse events such as nausea, vomiting, abdominal pain and diarrhea.”
Affected Gas-X Extra Strength Softgels — made to quickly break up gas bubbles in the digestive tract and relieve pressure, bloating and discomfort — are green capsules sold in 72-count and 120-count packages.
The 120-count product was distributed between April 13 and May 5, 2026, and had the UPC 300674350419 and Expiry Date of November 30, 2028. They can also be identified by the following Lot numbers: TL8K, YH9X and YH9Y.
The 72-count softgels have the UPC 300439005721, Lot number X78N and Expiry Date of November 20, 2028. They were distributed between May 5 and May 14, 2026.
While Haleon has not received any reports of adverse events to date, consumers are urged to stop taking the recalled product immediately. Shoppers should contact Haleon Consumer Relations — via phone, email or on the company’s online contact form, all found here — to return the product and request reimbursement.
The Gas-X Extra Strength Softgels are among the many products that have been recalled across the U.S. in recent months. Earlier this week, Target recalled two variations of its Up & Up brand baby wipes after potentially harmful bacteria was discovered during routine testing.
According to an announcement shared by the FDA, multiple customers who bought the wipes had complained to Target and the product’s manufacturer, Sapro Temizlik Urunleri, about discoloration and symptoms including skin irritation, eye irritation and infections. Simultaneously, the FDA conducted product testing that “identified the presence of Burkholderia cepacia complex and Burkholderia gladioli,” two bacteria that could cause life-threatening infections.
Last month, Pharmacal recalled one lot of its MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream because it was contaminated with Staphylococcus aureus, a bacterium that can cause skin issues. Affected creams were sold in six-ounce tubes at various retailers in the U.S. and on Amazon.
Staphylococcus aureus can cause Staph infections, resulting in boils, blisters and sores on the body, according to the Cleveland Clinic. The condition is usually treated with antibiotics or by applying a cream to the affected skin.
